# US 2016/0251345 A1 · Amorphous Salt of a Macrocyclic Inhibitor of HCV

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251345 A1
- Document ID: US20160251345A1
- Status: Published application
- Kind: A1
- Application number: 15/063,821
- Filed: 2016-03-08
- Published: 2016-09-01
- Earliest claimed: 2009-02-27
- Assignees: Janssen Pharmaceuticals, Inc.
- Applicants: Janssen Pharmaceuticals, Inc.
- Inventors: Peter Jozef Maria Van Remoortere; Roger Petrus Gerebern Vandecruys; Herman De Kock
- Web page: https://patentgrep.com/patent/US20160251345A1

## CPC

- C07D 417/14: containing three or more hetero rings
- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/14: for RNA viruses
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- A61K 31/4725: containing further heterocyclic rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The amorphous form of the sodium salt of the macrocyclic inhibitor of HCV of formula: as well as processes for manufacturing this salt.

## Claims

### Claim 1

The sodium salt of the compound of formula I:
in solid amorphous form.

### Claim at position 2

2-7. (canceled)

### Claim 8 (depends on 1)

A pharmaceutical composition comprising the sodium salt of the compound claim 1, and a pharmaceutically acceptable carrier.

### Claim at position 4

9-10. (canceled)
